Original Articles
Vol. 19 No. 1 (2004)
https://doi.org/10.4081/mm.2004.3019

Utilizzo di Etest nell’antibiogramma diretto da emocoltura su bacilli Gram negativi a crescita rapida e Staphylococcus spp.

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 25 February 2014
Published: 30 March 2004
1177
Views
1032
Downloads
Etest, Direct susceptibility testing, Blood coltures

Authors

Pietro Casella
casella.pietro@aovimercate.org
, .
Giovanna Confalonieri
, .
Donato Longo
, .
Stefano Muttini
, .
The objective of this study was to compare E test antibiotic gradient performed directly from positive blood coltures with Vitek 2 System for rapid susceptibility testing.A total of 47 strains of Gram negative rapid growers and 37 strains of Staphylococcus spp. (10 strains S. aureus and 27 coagulase negative) were investigated. Direct testing of susceptibility to amikacin, imipenem, piperacillin-tazobactam, and ciprofloxacin was evaluated for Gram negative strains, and to oxacillin,ofloxacin, and imipenem for Gram positive. The rate of correlation resulted 99.4% for Gram negative strains (187/188) and 97% for Gram positive strains (144/148).Major errors (i.e. reported as resistant by the Etest but shown to be sensible by the Vitek) were observed and regarding one strain of P. aeruginosa for imipenem and two strains of Staphylococcus coagulase negative for oxacillin and imipenem. Etest resulted useful for direct testing susceptibility from blood and may lead to cost reducttion.

Downloads

Download data is not yet available.

How to Cite



Utilizzo di Etest nell’antibiogramma diretto da emocoltura su bacilli Gram negativi a crescita rapida e Staphylococcus spp. (2004). Microbiologia Medica, 19(1). https://doi.org/10.4081/mm.2004.3019

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.